PDP1通过STAT3途径促进乳腺癌的进展
Yufeng Wang1,2, Huifen Dang2, Hui Qiao3
1Department of the First Clinical Medical College, Lanzhou University, Lanzhou, China.
Cell biochemistry and function
|April 3, 2024
概括
酸盐脱酶酸酶催化子单元1 (PDP1) 在乳腺癌 (BC) 中过度表达,并驱动瘤进展. 较低的PDP1水平与更好的患者存活率相关,表明PDP1是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 酸盐脱酶酸酶催化子单元1 (PDP1) 在细胞能量代谢中发挥作用.
- 异常的PDP1表达与包括癌症在内的各种疾病有关.
研究的目的:
- 研究PDP1在乳腺癌 (BC) 进展中的作用和机制.
- 在BC患者中确定PDP1表达的预后意义.
主要方法:
- 在BC组织中对PDP1表达的分析.
- 在体外研究涉及PDP1敲击和BC细胞系的过度表达.
- 在体内异种移植模型研究.
- RNA测序和KEGG通路分析.
- 西部斑点和CCK-8测定.
主要成果:
- 在BC组织中,PDP1显著过度表达,表达较低与改善的整体存活率相关.
- 在PDP1 knockdown中抑制了BC细胞的增殖,迁移和诱导的亡.
- RNA测序确定了JAK/STAT3信号通路作为PDP1影响的关键调解器.
- PDP1调节了p-STAT3水平,而STAT3抑制逆转了PDP1诱导的细胞活力.
结论:
- 通过激活STAT3信号通路,PDP1促进BC进展.
- 准PDP1和STAT3通路为乳腺癌提供了潜在的治疗策略.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


